NWPF

News ArchivesRead News

Parkinsons Disease Patches

Thursday February 25, 2010

Anita Choudhary

Parkinson's Disease Society - As a good method of treatment, Parkinson’s disease patch is being developed for treating Parkinson’s disease. This is being developed as a good method of treating it orally. The need to develop a skin patch for Parkinson’s existed, due to the digestive tract of people affected by the disease.

Skin patches are available for smoking cessation, heart problems, and pain control. A major research is going on for exploring new ways of treatment except oral medicines, of Parkinson’s.

The silicon patch that is being used in the clinical trials have Dopamine agonist , a drug commonly used to reduce the symptoms and help people lead a more normal life. ‘Neupro’ is the first trans-dermal patch that has been approved to treat symptoms of Parkinson’s disease.

The main symptoms of Parkinson’s include memory loss, decrease of cognitive skills, dementia. As it is a disorder of the central nervous system, motor skills are lost over time. These Parkinson’s disease patch medicines help in prolonging normal activity and suppressing the symptoms of the disease.

The main symptoms of this disease include stiffness and tremors in the limbs which is due to the reduction of Dopamine, chemical in the brain which controls movement in the body. Dopamine agonists clone dopamine and also stimulate the cells of the brain, just the way the normal chemical reacts.

Another Parkinsons disease patch that has been marketed is an active ingredient Rotigotine, which is a Dopamine receptor delivered through a skin patch. It is applied once to the skin and releases Ritigotine throughout 24 hours. Every day the patch needs to be changed. It is delivered to maintain stable rotigotine plasma in concentration level. The oral Dopamine agonists come in multiple doses but a patch is more effective and easy.

Recent News

Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement
Jul 19 - What Young-onset Parkinson’s Can Look Like
Jul 7 - Parkinson’s Patients Have a Higher Risk of Developing Melanoma — and Vice Versa, Study Finds
Jun 27 - The rogue protein behind Parkinson’s disease may also protect your gut
Jun 26 - Do Statins Increase Risk of Parkinson’s Disease? Some Researchers Think So
Jun 22 - A Confused Immune System Could Be Behind Parkinson's Disease
Jun 21 - Predicting cognitive deficits in people with Parkinson’s disease
Jun 20 - Gym offers classes in noncontact boxing for Parkinson’s patients
Jun 19 - Human Limitations Could Prevent Us From Advancing in Science. AI Could Help.
Jun 13 - Brain Cell Transplants Are Being Tested Once Again For Parkinson's
Jun 12 - Smell Test May Sniff Out Oncoming Parkinson's and Alzheimer's
Jun 8 - Smartphones Track Motor Function in Parkinson's Disease
Jun 8 - GKC Enrolls First Patient in Personal KinetiGraph Trial as Part of NPF’s Parkinson’s Outcomes Project
Jun 8 - Low-fat dairy intake may raise Parkinson's risk
Jun 6 - Patient Voices: Parkinson's Disease